Biltmore Family Office’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,123
Closed -$199K 253
2024
Q1
$199K Hold
12,123
0.04% 179
2023
Q4
$178K Sell
12,123
-26,351
-68% -$368K 0.04% 185
2023
Q3
$554K Buy
+38,474
New +$600K 0.13% 104

Other funds holding BMEZ

Biltmore Family Office's BMEZ Position: Q2 2024 in Review

Biltmore Family Office sold out of BlackRock Health Sciences Trust II (BMEZ) in Q2 2024, closing a stake of 12,123 shares — an estimated $199K sold.

Biltmore Family Office first reported a position in BMEZ in Q3 2023 and held it in 3 quarters. The position peaked at $554K in Q3 2023. 92 funds tracked by Wall St. Rank hold BMEZ as of Q2 2024.

  • Biltmore Family Office reported no remaining BlackRock Health Sciences Trust II position as of Q2 2024 after selling out during the quarter.
  • Biltmore Family Office sold 12,123 BlackRock Health Sciences Trust II shares in Q2 2024, an estimated $199K.
  • Biltmore Family Office first reported a position in BlackRock Health Sciences Trust II in Q3 2023 and held it in 3 quarters.
  • Biltmore Family Office's BlackRock Health Sciences Trust II position peaked at $554K in Q3 2023.
  • 92 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2024.

Based on Biltmore Family Office's 13F filing for Q2 2024, filed 7 Aug 2024.